Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2021 R21 RFA-CA-20-017 SWAGER, TIMOTHY M MASSACHUSETTS INSTITUTE OF TECHNOLOGY Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation Active
2001 R21 PAR-99-100 GUO, BAOCHUAN CLEVELAND STATE UNIVERSITY MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER Complete
2003 R21 PAR-01-104 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE ERROR-FREE DNA AMPLIFICATION FOR MUTATION DETECTION Complete
2009 R21 RFA-CA-08-007 TAINSKY, MICHAEL A WAYNE STATE UNIVERSITY SERUM BIOMARKERS FOR COLORECTAL CANCER DETECTION Complete
2013 R21 RFA-CA-13-001 VAN DAM, ROBERT MICHAEL UNIVERSITY OF CALIFORNIA LOS ANGELES COMPACT MICROFLUIDIC PET PROBE CONCENTRATOR FOR PRECLINICAL AND IN VITRO IMAGING Complete
2016 R21 RFA-CA-15-004 GARCIA, ANDRES J GEORGIA INSTITUTE OF TECHNOLOGY USHEAR TECHNOLOGY FOR CANCER CELL PURIFICAITON Complete
2006 R21 RFA-CA-06-002 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO DXMS-FACILITATED MEMBRANE PROTEIN CONSTRUCT DESIGN/CANCER Complete
2019 R21 RFA-CA-18-002 WU, YUN STATE UNIVERSITY OF NEW YORK AT BUFFALO Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection Complete
2000 R21 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2002 R21 PAR-01-106 BAKER, LAURENCE HOWARD UNIVERSITY OF MICHIGAN AT ANN ARBOR MOLECULAR DIAGNOSIS OF SARCOMAS Complete
2005 R21 RFA-CA-05-002 KRICHEVSKY, ANNA M. BRIGHAM AND WOMEN'S HOSPITAL TARGETING MIRNA IN BRAIN TUMORS. Complete
2008 R21 RFA-CA-07-033 LEVCHENKO, ANDRE JOHNS HOPKINS UNIVERSITY MICROFLUIDIC DEVICES FOR STUDYING CANCER SIGNAL TRANSDUCTION Complete
2005 R21 RFA-CA-05-002 CLAFFEY, KEVIN P. UNIVERSITY OF CONNECTICUT SCH OF MED/DNT IDENTIFICATION OF IMMUNE SELECTED BREAST CANCER ANTIGENS Complete
2008 R21 RFA-CA-07-033 SZMACINSKI, HENRYK UNIVERSITY OF MARYLAND BALTIMORE TIME-RESOLVED FLUOROMETRIC METHOD FOR ASSAY OF MULTIPLE BIOMARKERS Complete
2011 R21 RFA-CA-10-003 BLAIR, SARAH L UNIVERSITY OF CALIFORNIA SAN DIEGO NON-CIRCULATING MICROPARTICLES FOR IMPROVED LOCALIZATION AND RESECTION CANCER Complete
2015 R21 RFA-CA-14-003 HAYDEN, MELANIE STANFORD UNIVERSITY CELL-FREE TUMOR DNA IN CEREBRAL SPINAL FLUID DECODES TUMORS OF THE CENTRAL NERVOUS SYSTEM Complete
2018 R21 RFA-CA-17-010 SCHIBEL, ANNA ELECTRONIC BIOSCIENCES, INC. Microsatellite Sequencing to Enable Cancer Genotyping Complete
2022 R21 CA21-003 ARMITAGE, BRUCE A CARNEGIE-MELLON UNIVERSITY Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA Active
1999 R21 PAR-98-067 MEYER, TOBIAS DUKE UNIVERSITY CELL ARRAYS FOR SCREENING SIGNAL TRANSDUCTION PROCESSES Complete
2004 R21 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2007 R21 RFA-CA-07-015 WANG, NICHOLAS J UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NANO-SCALE DETECTION OF THE DISEASE PROTEOME Complete
2010 R21 RFA-CA-09-008 BARRETT, MICHAEL T TRANSLATIONAL GENOMICS RESEARCH INST HIGH DEFINITION CLONAL ANALYSES OF ARCHIVAL PANCREATIC ADENOCARCINOMA SAMPLES Complete
2014 R21 RFA-CA-13-001 ZENG, YONG UNIVERSITY OF KANSAS LAWRENCE INTEGRATED MICROFLUIDIC EXOSOME PROFILING FOR EARLY DETECTION OF CANCER Complete
2017 R21 RFA-CA-16-001 SOELLNER, MATTHEW B UNIVERSITY OF MICHIGAN AT ANN ARBOR Exquisitely selective turn-on probes of kinase activation and localization Complete
2021 R21 RFA-CA-20-017 BAR-PELED, LIRON MASSACHUSETTS GENERAL HOSPITAL Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors Active
2001 R21 PAR-99-100 YAMAMOTO, FUMIICHIRO BURNHAM INSTITUTE FOR MEDICAL RESEARCH TECHNOLOGY TO DETECT GENOME WIDE DNA METHYLATION CHANGES Complete
2003 R21 PAR-01-104 GOODLETT, DAVID ROBINSON INSTITUTE FOR SYSTEMS BIOLOGY PARALLEL PEPTIDE TANDEM MASS SPECTROMETRY (MS) Complete
2009 R21 RFA-CA-08-007 SODERLING, SCOTT H. DUKE UNIVERSITY MAPPING THE ARCHITECTURE OF CANCER SIGNALING PATHWAYS Complete
2013 R21 RFA-CA-13-001 WANG, ANDREW ZHUANG UNIV OF NORTH CAROLINA CHAPEL HILL DEVELOPMENT OF 3D ORGAN-SPECIFIC MODELS OF COLORECTAL CANCER METASTASIS Complete
2016 R21 RFA-CA-15-004 JAHNKE, FRANK SONATA BIOSCIENCES, INC. A NEW SAMPLE PREPARATION METHOD TO DELVE DEEPER INTO THE PROTEOME Complete
2006 R21 RFA-CA-06-002 LARGAESPADA, DAVID ANDREW UNIVERSITY OF MINNESOTA TWIN CITIES TRANSPOSON-BASED SOMATIC MUTAGENESIS/PROSTATE CANCER GENETICS Complete
2019 R21 RFA-CA-18-002 ZHU, YAZHEN UNIVERSITY OF CALIFORNIA LOS ANGELES Click Chemistry-Mediated Microfluidic Sorting for HCC CTCs Complete
2000 R21 PAR-98-067 CHANCE, MARK R YESHIVA UNIVERSITY DYNAMICS OF MACROMOLECULAR INTERACTIONS Complete
2002 R21 PAR-01-106 KENAN, DANIEL J. DUKE UNIVERSITY ENDOTHELIAL CELL MOLECULAR ALTERATIONS IN CANCER Complete
2002 R21 PAR-01-106 CHUONG, CHENG-MING UNIVERSITY OF SOUTHERN CALIFORNIA HIGH RESOLUTION MICROARRAY ANALYSIS OF CANCER Complete
2005 R21 RFA-CA-05-002 CHIOCCA, E. ANTONIO OHIO STATE UNIVERSITY IMAGING TRANSCRIPTIONAL ACTIVATION OF GLIOMAS Complete
2008 R21 RFA-CA-07-033 REHEMTULLA, ALNAWAZ UNIVERSITY OF MICHIGAN HTS FOR FADD KINASE INHIBITORS USING MOLECULAR IMAGING Complete
2011 R21 RFA-CA-10-003 BIEBERICH, CHARLES J. UNIVERSITY OF MARYLAND BALT CO CAMPUS APPLICATION OF AN INNOVATIVE TECHNOLOGY TO DEVELOP LOW TOXICITY KINASE INHIBITORS Complete
2015 R21 RFA-CA-14-003 LABAER, JOSHUA ARIZONA STATE UNIVERSITY-TEMPE CAMPUS MULTIPLEXED IN SOLUTION PROTEIN ARRAY (MISPA) FOR IDENTIFYING NOVEL PROTEIN INTERACTIONS IN CANCER AND FOR EARLY DETECTION OF IMMUNE RESPONSES IN PATHOGEN-INDUCED CANCERS Complete
2018 R21 RFA-CA-17-010 SHI, TUJIN BATTELLE PACIFIC NORTHWEST LABORATORIES An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells Complete
2022 R21 CA21-003 COUNTER, CHRISTOPHER M DUKE UNIVERSITY Adapting K-MDS to detect KRAS-mutant ctDNA Active
2004 R21 PAR-01-106 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS Complete
2007 R21 RFA-CA-07-017 XU, BAOGANG JONATHAN VANDERBILT UNIVERSITY MED CTR IDENTIFICATION OF BREAST TUMOR SECRETOME CHANGES THROUGHOUT TUMOR PROGRESSION Complete
2010 R21 RFA-CA-09-008 RIETHMAN, HAROLD WISTAR INSTITUTE TECHNOLOGY FOR DETECTION AND QUANTITATION OF TELOMERIC DNA ABERRATIONS IN CANCER Complete
2014 R21 RFA-CA-13-001 CHEN, XIAOWEI RESEARCH INST OF FOX CHASE CAN CTR A NOVEL ALLELE-SPECIFIC RNA-ISH FOR DIFFERENTIAL ALLELE-SPECIFIC EXPRESSION Complete
2017 R21 RFA-CA-16-001 SLATER, JOHN HUNDLEY UNIVERSITY OF DELAWARE A Vascularized, In Vitro, Organotropic Metastasis Model to Generate Dormant Micrometastases Complete
2021 R21 RFA-CA-20-017 CHEN, KAI UNIVERSITY OF SOUTHERN CALIFORNIA Novel Bisphosphonate PET Probes for Myeloma Bone Disease Active
2001 R21 PAR-99-100 WATT, PAUL M TELETHON INSTITUTE FOR CHILD HEALTH RES MECHANISMS OF GENOMIC INSTABILITY IN CANCER Complete
2003 R21 PAR-01-106 LABAER, JOSHUA HARVARD UNIVERSITY (MEDICAL SCHOOL) FUNCTIONAL PROTEOMICS OF BREAST CANCER Complete
2009 R21 RFA-CA-08-007 TYCKO, BENJAMIN COLUMBIA UNIVERSITY HEALTH SCIENCES OPTIMIZING MSNP FOR PROFILING DNA METHYLATION IN CANCERS AND PRECURSOR LESIONS Complete

Pages